Silvia Sánchez Herrero was born in Salamanca (Spain) in 2000. She obtained her degree in Biology from the University of Salamanca in 2022 and joined Dr. Oscar Palomares’s group in 2023 to carry out her Master’s project for the Master’s Degree in Immunology Research at the Complutense University of Madrid. Her work focused on the effects of different stimuli on dendritic cells in the context of food allergy, specifically peanut allergy. In 2024, she worked in Dr. Palomares’s group on a clinical trial to assess the capacity of the polybacterial mucosal MV130 formulation to enhance vaccine efficacy. Currently, Silvia is pursuing an industrial doctorate funded by CAM in collaboration with Inmunotek, aimed at studying the metabolic and epigenetic mechanisms of MV130 on dendritic cells and epithelial cells in the context of asthma.

PhD Student

silvis09@ucm.es